↓ Skip to main content

Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?

Overview of attention for article published in Cost Effectiveness and Resource Allocation, August 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is Aducanumab treatment developed to prevent progression of Alzheimer's disease cost-effective in Turkey?
Published in
Cost Effectiveness and Resource Allocation, August 2023
DOI 10.1186/s12962-023-00463-7
Pubmed ID
Authors

Vahit Yigit, Selin Kalender, Iskender Cetinturk

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 25%
Student > Ph. D. Student 1 13%
Unspecified 1 13%
Unknown 4 50%
Readers by discipline Count As %
Unspecified 1 13%
Biochemistry, Genetics and Molecular Biology 1 13%
Business, Management and Accounting 1 13%
Psychology 1 13%
Materials Science 1 13%
Other 0 0%
Unknown 3 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2023.
All research outputs
#3,447,838
of 24,253,070 outputs
Outputs from Cost Effectiveness and Resource Allocation
#79
of 463 outputs
Outputs of similar age
#26,595
of 179,383 outputs
Outputs of similar age from Cost Effectiveness and Resource Allocation
#1
of 13 outputs
Altmetric has tracked 24,253,070 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 463 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,383 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.